Webinars & Whitepapers →
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
Managing director, the Foundry Group
Software Engineer at Skelmir
Chairman, CEO, & Founder, Alexandria Real Estate Equities
Partner at New Enterprise Associates
Director, Life Sciences Institute, University of Michigan
CEO and Co-Founder, Tamr
March 18, 2020 · San Diego
Matthew Scholz is the CEO of Immusoft, a (currently) Seattle based biotech startup that is commercializing technology to program the human immune system.
If Seattle is to occupy a future place of dominance in the biotech world, it must foster more of an “incubator” culture. There is a “valley of death” between the well-funded... Read more »
Sponsored · Whitepaper
Best practices to drive digital adoption in life sciences
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
Monitor spending and save meaningful dollars with life sciences-specific rewards
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.